BA
The Boeing Company
BA has a slight edge over CRAI overall, supported by stronger fundamentals and stronger valuation.
CRAI
CRA International, Inc.
CRAI's outlook is improving, though it still trails on the overall score.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CRAI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
CRAI's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CRAI in the historical PE scenario, which offers more potential upside but is not a forecast.
CRAI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $130 | -35% |
| Fair | 20x | $162 | -19% |
| Forward | 22x | $199 | — |
| Current | 25x | $199 | — |
| Expensive | 26x | $204 | +2.6% |
Historical ranges are pointers, not guarantees.
CRAI's PE is in its expensive range at 25x. If earnings grow as analysts expect, today's price would be 22x next year's earnings, in its fair range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CRAI on the outlook, with more favorable profitability expectations.
CRAI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CRAI, with profitability holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CRAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.25 | +16% |
| Q3 2026 | $7.99 | -4% |
| Q2 2026 | $7.52 | -9% |
| Q1 2026 | $7.21 | -2.7% |
| Q4 2025 | $8.14 | +21% |
| Q3 2025 | $8.32 | +35% |
| Q2 2025 | $8.26 | +45% |
| Q1 2025 | $7.41 | +21% |
| Q4 2024 | $6.74 | +25% |
CRAI has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CRAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $214.9M | +16% |
| Q2 2026 | $210.8M | +13% |
| Q1 2026 | $201M | +11% |
| Q4 2025 | $197M | +12% |
| Q3 2025 | $185.9M | +11% |
| Q2 2025 | $186.9M | +9% |
| Q1 2025 | $181.9M | +5.9% |
| Q4 2024 | $176.4M | +9.2% |
CRAI's revenue has grown year over year for 12 quarters in a row: $215M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +1.9 points |
| Q2 2026 | 11% | +0.6 points |
| Q1 2026 | 9% | -5.1 points |
| Q4 2025 | 10% | -1.7 points |
| Q3 2025 | 9.3% | -1.7 points |
| Q2 2025 | 11% | +4 points |
| Q1 2025 | 14% | +2.6 points |
| Q4 2024 | 12% | +1.6 points |
CRAI has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CRAI on cash flow, with more consistent year-over-year improvement.
CRAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $73.2M | +104% |
| Q2 2026 | -$6.1M | -230% |
| Q1 2026 | -$116.5M | -$35.6M |
| Q4 2025 | $59M | -14% |
| Q3 2025 | $35.9M | +26% |
| Q2 2025 | $4.7M | +$5.2M |
| Q1 2025 | -$81M | -$17.2M |
| Q4 2024 | $68.8M | +15% |
CRAI still generates free cash flow, though less than at its 2026 peak: $10M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CRAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -80K shares |
| 1 year | -4.4% | -294K shares |
| 3 years | -11% | -756K shares |
| 5 years | -16% | -1.2M shares |
| Available history | -23% | -1.8M shares |
CRAI has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $27.8M |
| Q1 2026 | $21.5M |
| Q4 2025 | — |
| Q3 2025 | $4M |
| Q2 2025 | $43.2M |
| Q1 2025 | — |
| Q4 2024 | — |
CRAI spent $49M buying back its own shares over the past year, up 4.6% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CRAI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | -0.3x | Net Cash |
CRAI has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CRAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.2 | Neutral |
| Stochastic | 74.6 | Neutral |
CRAI's weekly RSI is 64 (neutral) and its Stochastic is 75 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CRAI on valuation relative to its sector.
CRAI PE vs Industrials Sector
| Metric | CRAI | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 24x | 3.6% above |
| PE % | 79 | 58 | 21 pts above |
CRAI is trading at 25x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CRAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.1 | 7.7% above |
| 20 week MA | $174.8 | 14% above |
| 50 week MA | $171.8 | 16% above |
| 100 week MA | $178.3 | 12% above |
| 200 week MA | $154.8 | 29% above |
CRAI has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CRAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $53.6 | $50.5 | -5.7% |
| 2021 | $50.5 | $92.3 | +83% |
| 2022 | $92.3 | $120.0 | +30% |
| 2023 | $120.0 | $98.9 | -18% |
| 2024 | $98.9 | $186.8 | +89% |
| 2025 | $186.8 | $206.2 | +10% |
| 2026 YTD | $206.2 | $199.3 | -3.4% |
CRAI has the edge over BA on returns for 2026, with the stronger performance.